SpaceX IPO Opens to Retail Investors Through Major Brokerage Platforms Singapore Manufacturing Output Rises in April Powered by AIDriven Demand Chinas AI Media System Ignores Japanese Politicians Condolences After Coal Mine Disaster Pokmon Card Market Surges Nostalgia Speculation and Celebrity Influence Drive MillionDollar Sales Markets Shift Expectations Fed Rate Hike Possible as Soon as December After Inflation Surge AI Agents on Base Accelerate SpaceX IPO Research to 12 Minutes Cheche Group CCG Q4 2024 Earnings EPS Beats Estimates by 4012 Revenue Not Reported Falcons Beyond Global Inc FBYD Q1 2026 Earnings Loss Reported as Stock Rises on Operational Progress GTES Q1 2026 Earnings EPS Beat Drives Positive Market Reaction BGMS Q3 2024 Earnings Significant EPS Beat Tempered by Revenue Uncertainty Bolt Biotherapeutics Q1 2026 Earnings WiderThanExpected Loss Amid PreRevenue Stage OLLI Q1 2026 Earnings EPS Misses Estimates Amid Challenging Retail Environment Eagle Point Credit Notes ECCW Steady Near Par as FixedIncome Market Consolidates Bitdeer Technologies BTDR Slides 181 to 1465 as Trading Volume Highlights Sector Pressure FSK Holds Steady Near Key Support as Consolidation Continues First Western Financial MYFW Holds Steady Near Support Amid Low Volatility Consensus Cloud Solutions CCSI Gains 26 as Stock Approaches Key Resistance Timex Group India Achieves Landmark Revenue of Rs 800 Crore for FY26 Moderna Inc MRNA Q1 2026 Earnings Narrowerthanexpected loss as cost controls offset revenue headwinds Bluemount Holdings Limited BMHL Rises Modestly as Key Support Holds Baozun Inc BZUN Rallies 36 as Shares Test Key Resistance Near 272 Norfolk Southern NSC Gains 18 as Railroad Stock Holds Above Key Support Lockheed Martin LMT Gains 114 as Defense Sector Momentum Continues Support and Resistance in Focus Atlas Critical Minerals Slips 135 as Technical Consolidation Persists Elite Express Holding Inc ETS Drops 31 to 053 Nears Key Support at 050 US GoldMining Inc Warrant USGOW Plunges 34 as Penny Stock Hits Support Floor ABVC BioPharma Surges 13 Key Levels and Potential Scenarios